We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TCLIF market cap is 26.98M. The company's latest EPS is EUR -0.1085 and P/E is -5.44.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.94M | 3.22M | 1M | 1.71M | 1.37M |
| Operating Income | -6.75M | -4.5M | -4.05M | -4.51M | -6.28M |
| Net Income | -6.14M | -3.79M | -3.91M | -3.76M | -4.96M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 9.56M | 10.51M | 10.55M | 11.83M | 13.94M |
| Total Liabilities | 10.1M | 10.59M | 13.78M | 13.1M | 13.4M |
| Total Equity | -532k | -80k | -3.24M | -1.27M | 545k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -4.73M | -3.69M | -3.32M | -3.88M | -5.27M |
| Investing | -1.11M | -317k | -192k | -524k | -740k |
| Financing | 1.89M | 4.53M | 4.41M | 4.56M | 6.03M |
| Market Cap | 26.98M |
| Price to Earnings Ratio | -5.44 |
| Price to Sales Ratio | 19.73 |
| Price to Cash Ratio | 10.85 |
| Price to Book Ratio | 49.51 |
| Dividend Yield | - |
| Shares Outstanding | 45.73M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.59 |
| 52 Week Low | 0.59 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Theraclion (CE) |
| Address |
240 avenue pierre brossolette malakoff, hauts-de-seine 92240 |
| Website | https://www.theraclion.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
